CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- 4 Other acquisition Co-CEO & President acquired 373,857 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 9,346,434 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 94,849,203 shares at $0.97 ($92,003,727)
- 4 Open-market buy Co-CEO & President bought 5,809,132 shares at $0.97 ($5,634,858)
- 4 Open-market buy Chief Financial Officer bought 36,215 shares at $0.97 ($35,129)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Executive Officer acquired 21,135 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 7 · 130 filings